← Back to search

MaxCyte Inc

MXCT · NASDAQ

Research and Development in Biotechnology

MaxCyte is a leading commercial cell-engineering company focused on providing enabling platform technologies to advance innovative cell-based research as well as next-generation cell therapeutic discovery, development and commercialization.

ESG Scores

Overall ESG
4.1
Environmental
6.3
Social
3.4
Governance
5.7

Public ESG Grades

Overall: BB (Medium)
E: BS: BBG: B

Gender Diversity

Female Directors0.11109999999999999%
CEO GenderMale

Market Data

Price$0.83-0.02 (-2.31%)
Market Cap$91M
P/E Ratio—
EPS$—
52W High$2.96
52W Low$0.64
Beta1.52